Radiotherapy and diagnostic capacity in relation to the changing cancer burden in the Baltic States
DOI:
https://doi.org/10.2340/ao.v65.45442Keywords:
Radiotherapy, Health Resources, Workforce, Technology Assessment, Biomedical, Baltic States, Health Services Accessibility, NeoplasmsAbstract
Background and purpose: Cancer mortality rates in the Baltic States (Estonia, Latvia, and Lithuania) exceeds the European Union (EU) average, in part due to limited access to radiation therapy (RT). We updated RT capacity and utilization to inform regional planning.
Patient/material and methods: We conducted a census of all 11 RT centres (2016–2023) via a standardized questionnaire, cross-validated with national registries and international databases. We compared technology availability, workforce, and utilization with EU countries in relation to the present cancer burden and projections to 2050. This multicentre observational study adhered to STrengthening the Reporting of OBservational Studies in Epidemiology (STROBE) guidelines.
Results: Only 35–42% of cancer patients received RT, below the 50% recommendation. Linear accelerator availability ranged from 3.8 to 5.1 per million inhabitants, figures that are almost half those seen in EU countries with higher Gross Domestic Product (GDP) per capita. While the use of intensity modulated RT, volumetric modulated arc therapy and stereotactic RT increased, staffing levels has remained static in recent years. Mortality-to-incidence ratio correlated negatively with GDP (r = –0.7) and RT capacity
(r = –0.7).
Interpretation: Despite technological progress in the Baltic States, major gaps persist in RT access and workforce levels. Baltic States still underperform compared to EU countries with higher GDP per capita in terms of equipment availability, workforce capacity, and overall cancer outcomes. Future-oriented strategic investments, based on regional collaboration and shared infrastructure are urgently needed, including the development of a regional particle therapy centre, to ensure equitable access to state-of-the art advanced cancer care across the Baltic States.
Downloads
References
Abdel Wahab M, Gondhowiardjo SS, Rosa AA, Lievens Y, El Haj N, Polo Rubio JA, et al. Global radiotherapy: current status and future directions – white paper. JCO Glob Oncol. 2021;7:827–42.
https://doi.org/10.1200/GO.21.00029 DOI: https://doi.org/10.1200/GO.21.00029
World Bank. Data for Estonia, Latvia, Lithuania [Internet]. World Bank Open Data; [cited 2025 Feb 05]. Available from: https://data.worldbank.org/?locations=EE-LT-LV
Economist Impact. Sustainable oncology care: a European perspective [Internet]. Economist Impact; 2025 [cited 2025 Feb 05]. Available from: https://impact.economist.com/perspectives/sites/default/files/download/sustainable_oncology_care_a_european_perspective_report.pdf
Hofmarcher T, Berchet C, Dedet G. Access to oncology medicines in EU and OECD countries. Paris: OECD Publishing; 2024. OECD Health Working Papers No. 170.
International Agency for Research on Cancer. Cancer today: data visualization [Internet]. Global Cancer Observatory; 2025 [cited 2025 Feb 05]. Available from: https://gco.iarc.fr/today/en/dataviz/bars?mode=population&types=1&populations=100_191_196_203_208_233_246_250_276_300_348_372_380_40_428_440_442_470_528_56_616_620_642_703_705_724_752_940&values_position=out&nb_items=-1&populations_h=233_428_440
Ferlay J, Laversanne M, Ervik M, Lam F, Colombet M, Mery L, et al. Global Cancer observatory: cancer tomorrow (version 1.1) [Internet]. Lyon, France: IARC; 2024 [cited 2025 Mar 31]. Available from: https://gco.iarc.who.int/tomorrow
International Agency for Research on Cancer. Cancer tomorrow: trends data visualization [Internet]. Global Cancer Observatory; 2025 [cited 2025 Feb 05]. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/trends?multiple_populations=1&populations=428_440_233&types=1&sexes=2
Borràs JM, Lievens Y, Dunscombe P, Coffey M, Malicki J, Corral J, et al. The optimal utilization pro- portion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol. 2015;116(1):38–44. Fel! Ogiltig hyperlänkreferens. DOI: https://doi.org/10.1016/j.radonc.2015.04.018
Borras JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, et al. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO HERO analysis. Radiother Oncol. 2016;119(1):5–11.
https://doi.org/10.1016/j.radonc.2016.02.016 DOI: https://doi.org/10.1016/j.radonc.2016.02.016
Grau C, Defourny N, Malicki J, Dunscombe P, Borras JM, Coffey M,
et al; HERO consortium. Radiotherapy equipment and departments in the European countries: final results from the ESTRO HERO survey. Radiother Oncol. 2014;112(2):155–64.
https://doi.org/10.1016/j.radonc.2014.08.029 DOI: https://doi.org/10.1016/j.radonc.2014.08.029
Lievens Y, Defourny N, Coffey M, Borras JM, Dunscombe P, Slotman B, et al; HERO Consortium. Radiotherapy staffing in the European countries: final results from the ESTRO HERO survey. Radiother Oncol. 2014;112(2):178–86.
https://doi.org/10.1016/j.radonc.2014.08.034 DOI: https://doi.org/10.1016/j.radonc.2014.08.034
Mineikytė R, Janulionis E, Atkočius V, Jaruševičius L, Plieskienė A, Gečas J. The changes of radiotherapy in Lithuania: infrastructure, utilization rate, and cost. Acta Med Litu. 2016;23(1):17–23.
https://doi.org/10.6001/actamedica.v23i1.3266 DOI: https://doi.org/10.6001/actamedica.v23i1.3266
Organisation for Economic Co-operation and Development. EU country cancer profile: Estonia 2025. Paris: OECD Publishing; 2025.
Organisation for Economic Co-operation and Development. EU country cancer profile: Lithuania 2025. Paris: OECD Publishing; 2025
Organisation for Economic Co-operation and Development. EU country cancer profile: Latvia 2025. Paris: OECD Publishing; 2025.
Dosanjh M, Gershan V, Wendling EC, Khader JS, Ige TA, Ristova M, et al. Access to diagnostic imaging and radiotherapy technologies for patients with cancer in the Baltic countries, eastern Europe, central Asia, and the Caucasus: a comprehensive analysis. Lancet Oncol. 2024;25(11):1487–95.
https://doi.org/10.1016/S1470-2045(24)00452-2 DOI: https://doi.org/10.1016/S1470-2045(24)00452-2
Bray F, Colombet M, Aitken JF, Bardot A, Eser S, Galceran J, et al, editors. Cancer incidence in five continents, Vol XII. IARC CancerBase No 19. Lyon: IARC; 2023 [cited 2025 Mar 31]. Available from: https://ci5.iarc.who.int
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
https://doi.org/10.3322/caac.21834 DOI: https://doi.org/10.3322/caac.21834
Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2024;155(3):350–372.
https://doi.org/10.1002/ijc.35278 DOI: https://doi.org/10.1002/ijc.35278
World Health Organization. Mortality data platform [Internet]. [cited 2025 Feb 05]. Available from: https://platform.who.int/mortality
United Nations. World population prospects – population division [Internet]. [cited 2025 Feb 5]. Available from: https://population.un.org/wpp/
Statistics Estonia. [Internet]. [cited 2025 Feb 05]. Available from: https://andmed.stat.ee/en/stat
Central Statistical Bureau of Latvia. [Internet]. Official statistics Portal; [cited 2025 Feb 05]. Available from: https://stat.gov.lv/lv/statistikas-temas
Statistics Lithuania. [Internet]. Official Statistics Portal; [cited 2025 Feb 05]. Available from: https://osp.stat.gov.lt/
Estonian Health Statistics and Health Research Database [Internet]. [cited 2025 Feb 05]. Available from: https://statistika.tai.ee/index.html
Latvian Health Statistics Database [Internet]. [cited 2025 Feb 05]. Available from: https://statistika.spkc.gov.lv/pxweb/lv/Health/
Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, van den Bogaert W. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO QUARTS work package 1. Radiother Oncol. 2005;75(3):349.E1–6.
https://doi.org/10.1016/j.radonc.2004.12.005 DOI: https://doi.org/10.1016/j.radonc.2004.12.005
Eurostat. Healthcare resource statistics: technical resources and medical technology [Internet]. [cited 2025 Feb 5]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_resource_statistics_-_technical_resources_and_medical_technology
World Health Organization. Technical specifications of radiotherapy equipment for cancer treatment. Geneva: WHO; 2021.
Paļskis K, Korobeinikova E, Bogorada-Saukuma D, Purkalne G, Mikolaichuk E, Eglitis J, et al. Particle ther- apy – future for the Baltic states? Synthesis of the expert workshop report. Health Technol. 2024;14:965–72. https://doi.org/10.1007/s12553-024-00875-2 DOI: https://doi.org/10.1007/s12553-024-00875-2
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Erika Korobeinikova, Kristaps Paļskis, Manjit Dosanjh, Freddie Bray, Eduard Gershkevitsh, Inga Balode, Alvis Bernans, Gaļina Boka, Laimonas Jaruševičius, Zanda Liepa, Māris Mežeckis, Aista Plieskienė, Maija Radziņa, Romas Skomskis, Giedrė Smailytė, Sandra Stepiņa, Jonas Venius
This work is licensed under a Creative Commons Attribution 4.0 International License.
